Contribute to Manishpatel012/MRP-15FEB development by creating an account on GitHub.
mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...
Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during and after narrow-band UVB phototherapy: a reply.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback